Loading...

Trulieve Cannabis Corp.

TCNNFPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$9.63
$0.46(5.02%)
U.S. Market opens in 7h 36m

Trulieve Cannabis Corp. Fundamental Analysis

Trulieve Cannabis Corp. (TCNNF) shows weak financial fundamentals with a PE ratio of -15.68, profit margin of -9.85%, and ROE of -9.69%. The company generates $1.2B in annual revenue with weak year-over-year growth of 1.30%.

Key Strengths

Cash Position13.86%
PEG Ratio-0.64
Current Ratio4.43

Areas of Concern

ROE-9.69%
We analyze TCNNF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 10.2/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
10.2/100

We analyze TCNNF's fundamental strength across five key dimensions:

Efficiency Score

Weak

TCNNF struggles to generate sufficient returns from assets.

ROA > 10%
-4.25%

Valuation Score

Excellent

TCNNF trades at attractive valuation levels.

PE < 25
-15.68
PEG Ratio < 2
-0.64

Growth Score

Moderate

TCNNF shows steady but slowing expansion.

Revenue Growth > 5%
1.30%
EPS Growth > 10%
24.39%

Financial Health Score

Excellent

TCNNF maintains a strong and stable balance sheet.

Debt/Equity < 1
0.58
Current Ratio > 1
4.43

Profitability Score

Weak

TCNNF struggles to sustain strong margins.

ROE > 15%
-968.80%
Net Margin ≥ 15%
-9.85%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is TCNNF Expensive or Cheap?

P/E Ratio

TCNNF trades at -15.68 times earnings. This suggests potential undervaluation.

-15.68

PEG Ratio

When adjusting for growth, TCNNF's PEG of -0.64 indicates potential undervaluation.

-0.64

Price to Book

The market values Trulieve Cannabis Corp. at 1.58 times its book value. This may indicate undervaluation.

1.58

EV/EBITDA

Enterprise value stands at 4.51 times EBITDA. This is generally considered low.

4.51

How Well Does TCNNF Make Money?

Net Profit Margin

For every $100 in sales, Trulieve Cannabis Corp. keeps $-9.85 as profit after all expenses.

-9.85%

Operating Margin

Core operations generate 12.64 in profit for every $100 in revenue, before interest and taxes.

12.64%

ROE

Management delivers $-9.69 in profit for every $100 of shareholder equity.

-9.69%

ROA

Trulieve Cannabis Corp. generates $-4.25 in profit for every $100 in assets, demonstrating efficient asset deployment.

-4.25%

Following the Money - Real Cash Generation

Operating Cash Flow

Trulieve Cannabis Corp. produces operating cash flow of $274.57M, showing steady but balanced cash generation.

$274.57M

Free Cash Flow

Trulieve Cannabis Corp. generates strong free cash flow of $230.21M, providing ample flexibility for dividends, buybacks, or growth.

$230.21M

FCF Per Share

Each share generates $1.20 in free cash annually.

$1.20

FCF Yield

TCNNF converts 12.35% of its market value into free cash.

12.35%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-15.68

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.64

vs 25 benchmark

P/B Ratio

Price to book value ratio

1.58

vs 25 benchmark

P/S Ratio

Price to sales ratio

1.55

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.58

vs 25 benchmark

Current Ratio

Current assets to current liabilities

4.43

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.10

vs 25 benchmark

ROA

Return on assets percentage

-0.04

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How TCNNF Stacks Against Its Sector Peers

MetricTCNNF ValueSector AveragePerformance
P/E Ratio-15.6829.88 Better (Cheaper)
ROE-9.69%682.00% Weak
Net Margin-9.85%-46037.00% (disorted) Weak
Debt/Equity0.580.42 Weak (High Leverage)
Current Ratio4.434.49 Strong Liquidity
ROA-4.25%-16420.00% (disorted) Weak

TCNNF outperforms its industry in 2 out of 6 key metrics, but lagging in ROE.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Trulieve Cannabis Corp.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

36.80%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-211.58%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

65.38%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ